Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00621179 · ClinicalTrials.gov registry record · Phase 4
Endometrial Markers and Response of Endometriosis Patients to Prolonged GnRH Agonist Prior to IVF
A Phase 4 study of Infertility and Endometriosis, sponsored by Colorado Center for Reproductive Medicine.
- Completed
- Registry status
- Phase 4
- Development phase
- 37
- Enrollment target
- 1
- Study location
NCT00621179 is a Phase 4 study of Infertility and Endometriosis that has completed, run by Colorado Center for Reproductive Medicine. The registered enrollment target is 37 participants, below the 7,589-participant average among 74 other Infertility trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00621179, a Phase 4 study of Infertility and Endometriosis, has completed, sponsored by Colorado Center for Reproductive Medicine.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 37 participants
- Enrollment target
- 1
- Study location
Study Summary
This prospective randomized trial evaluates whether one can predict which infertile women with endometriosis who are candidates for in vitro fertilization will benefit from prolonged therapy with a GnRH agonist by the determination of the absence of endometrial expression of the integrin, alpha v, beta 3 vitronectin. This is a prospective randomized trial in which all patients will undergo endometrial biopsy prior to initiation of ovarian stimulation for in vitro fertilization and then undergo randomization to a three month course of a depot preparation of the GnRH agonist leuprolide acetate in depot suspension prior to ovarian stimulation or standard therapy. prio
Conditions Studied
Interventions
- OTHER No intervention
- DRUG Leuprolide acetate in depot suspension
Study Locations (1)
Colorado
- Colorado Center for Reproductive Medicine - Lone Tree
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 37 participants |
| Start Date | 2003-03 |
| Est. Completion | 2010-01 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00621179
The ClinicalTrials.gov registry entry for NCT00621179 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 37 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 7,589-participant average among 74 other Infertility trials with a reported enrollment target (100% lower). The listed sponsor is Colorado Center for Reproductive Medicine, which has 7 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Infertility appearing as the primary indexed condition, and to 2 interventions - of which No intervention is the first listed.
NCT00621179 reports 1 study location spanning 1 distinct geographic area - top geographies include Colorado.
Frequently Asked Questions
What is clinical trial NCT00621179 about?
NCT00621179 is a clinical study titled "Endometrial Markers and Response of Endometriosis Patients to Prolonged GnRH Agonist Prior to IVF". This prospective randomized trial evaluates whether one can predict which infertile women with endometriosis who are candidates for in vitro fertilization will benefit from prolonged therapy with a GnRH agonist by the determination of the absence of endometrial expression of the integrin, alpha v, b...
What is the current status of trial NCT00621179?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 37 participants. The study started on 2003-03. Estimated completion is 2010-01.
What conditions does trial NCT00621179 study?
This clinical trial studies the following conditions: Infertility, Endometriosis.
What interventions are being tested in trial NCT00621179?
The interventions under investigation include: No intervention (OTHER), Leuprolide acetate in depot suspension (DRUG).
Who is sponsoring clinical trial NCT00621179?
This trial is sponsored by Colorado Center for Reproductive Medicine, which has 7 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00621179 being conducted?
This trial has 1 study location across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Infertility
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
GnRH for Luteal Support in IVF/ICSI/FET Cycles
RECRUITING · Phase 4
-
Randomized Controlled Trial of Combined Letrozole and Clomid (CLC II) Versus Letrozole Alone for Women With Anovulation
ACTIVE NOT RECRUITING · Phase 4
-
Vaginal Compared to Intramuscular Progesterone for Frozen Embryo Transfer
COMPLETED · Phase 4
-
Concomitant Administration of FSH With HCG Improves Oocyte Maturation and Quality Double -Blinded Randomized Trial
COMPLETED · Phase 4
-
Menopur Mixed Protocol
COMPLETED · Phase 4
-
Gamete Treatment to Correct Fertilization Failure
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.